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Background: The western barred bandicoot, Perameles bougainville, is an endangered 
Australian marsupial species whose survival is threatened by a papillomatosis and 
carcinomatosis syndrome. Investigations to characterize this syndrome would benefit from 
species-specific clinical chemistry data. 
Objectives: The purpose of this study was to determine plasma biochemical reference values 
and to determine enzyme activities in various tissues of P. bougainville.  
Methods: Heparinized blood samples were collected by jugular venipuncture from 53 clinically 
healthy bandicoots of both sexes and at 3 geographic locations. Plasma was analyzed for routine 
clinical chemistry variables using an automated biochemistry analyzer. Tissues obtained 
following humane euthanasia of 3 bandicoots were analyzed for alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), alkaline phosphatase (ALP), creatine kinase (CK), α-amylase 
(AML) and γ-glutamyltransferase (GGT) activities. 
Results: Significant differences in results were found for animals based on geographic location 
and sex, so results were expressed as minimum and maximum values. A population reference 
interval was calculated for AST activity (20–283 U/L). ALT was found mainly in liver, with 
lower levels in cardiac and skeletal muscle and kidneys. AST was detectable in many tissues, 
including heart, liver, kidneys and central nervous system; CK was found in skeletal and cardiac 
muscle and central nervous system; AML was found in pancreas; and GGT was found mainly in 
kidneys with less in intestines and pancreas.  
Conclusions: These findings will facilitate the interpretation of clinical chemistry results from P. 
bougainville and thereby inform population management and clinical decision-making. 
 The western barred bandicoot, Perameles bougainville, is an endangered Australian marsupial 
species that once occurred widely across southern mainland Australia until animal and habitat 
destruction led to its rapid demise.
1–3 Clinical chemistry data from clinically normal P. 
bougainville are lacking, which hinders efforts to monitor the health of natural and captive 
populations. A papillomatosis and carcinomatosis syndrome has been identified in P. 
bougainville and guidelines for the assessment of clinical chemistry results from affected 
individuals were required.
4 The purpose of the current study was to develop such reference 
values for healthy western barred bandicoots from 5 geographical locations in Western Australia. 
We also measured the distribution of 6 enzymes in 9 tissues. 
Three bandicoots were anesthetized using isoflurane gaseous anaesthetic, examined and 
humanely euthanized due to debilitatation by the papillomatosis and carcinomatosis syndrome (2 
females) and an ulcerating scrotum associated with unilateral testicular torsion (1 male). Spleen, 
lung, liver, heart, kidney, pancreas, small intestine, skeletal muscle, and central nervous system 
samples were immediately collected from these animals and stored at –20°C for up to 6 months. 
Each tissue sample was thawed weighed, homogenized and sonicated in phosphate buffered 
saline according to published methods.
5 The supernatants were analyzed using a RX Daytona 
automated biochemistry analyzer (Randox Laboratories, Crumlin, UK) for alanine 
aminotransferase (ALT, EC 2.6.1.2), aspartate aminotransferase (AST, EC 2.6.1.1), alkaline 
phosphatase (ALP, EC 3.1.3.1), creatine kinase (CK, EC 2.7.3.2), α-amylase (AML, EC 3.2.1.1) 
and γ-glutamyltransferase (GGT, EC 2.3.2.2) activities. Enzyme activity was expressed as units 
(U) per gram of wet tissue weight.  
Clinical chemistry data obtained from 53 clinically normal bandicoots were included in 
the study, including 4 (2 males, 2 females) from Dorre Island; 6 (3 males, 3 females) from  
Bernier Island; 23 (15 males, 8 females) from Heirisson Prong; 15 (4 males, 11 females) from 
Dryandra Woodland; and 5 (4 males, 1 female) from Kanyana Wildlife Rehabilitation Centre. 
Two samples were from sub-adults at Dryandra and 8 samples were from lactating females at 
Dorre Island (n = 2), Dryandra (n = 2) and Heirisson Prong (n = 4). Animals were trapped 
overnight in baited Sheffield or Elliot traps or hand-netted as appropriate, then anesthetized using 
isoflurane gaseous anesthetic delivered by mask. A thorough clinical examination was performed 
and blood samples were collected by jugular venipuncture. Approximately 600–800 µL of blood 
was distributed evenly between two 400-µL lithium–heparin collection tubes (Microtainer, 
Becton-Dickinson, North Ryde, NSW, Australia). Tubes were centrifuged and the plasma was 
pipetted into labeled Eppendorf tubes and frozen at -20 °C for up to 5 days prior to submission to 
the Murdoch University clinical pathology laboratory. Plasma samples were analyzed using a 
RX Daytona automated biochemistry analyzer (Randox Laboratories, Crumlin, UK) for total 
bilirubin, calcium, cholesterol, creatinine, glucose, phosphate, urea, total protein, and albumin 
concentrations, and ALP, ALT, AST and CK activities. Globulins concentration and the 
albumin/globulin ratio were calculated. 
The D’Agostino-Pearson test was used to check data for Gaussian distribution and 
Levene’s test was used to assess homogeneity of variances. The Kruskall-Wallis test was used to 
compare the means of data sets with homogeneous variances. When raw data sets failed 
Levene’s test, data were transformed using the logarithm, square root or reciprocal of the raw 
data and transformed data were subjected to the above statistical procedures. Using this protocol, 
the effects of geographic location, sex and lactation status were investigated for each analyte 
using SPSS 15.0.0 for Windows (SPSS Inc, Chicago, IL, USA). Statistical significance was set at 
P < .05. A Gaussian tolerance interval was calculated for AST according to published methods.
6  
The activities of ALP, ALT, AST, CK, AML and GGT in various tissues were graphed 
(Figure 1) and the minimum and maximum values for the 15 clinical chemistry analytes were 
tabulated (Table 1). Results from bandicoots at different geographical locations were 
significantly different for ALT (P = .001) and CK (P = .008) activities, and albumin (P = .010), 
total bilirubin (P < .001; n = 49), cholesterol (P < .001), glucose (P = .002), total protein (P = 
.006), phosphate (P = .012), and globulins (P < .001) concentrations.  Significant differences 
also were observed between males, females, and lactating females for ALT activity (P = .002) 
and glucose concentration (P = .015). Only plasma AST activity had a data set transformable to a 
parametric distribution, using the reciprocal transformation. The reference interval calculated for 
AST activity was 20–283 U/L. 
  To our knowledge, only one previous report has been published of clinical chemistry 
values for peramelemorphs (bandicoots and bilbies) in which individual values were provided for 
AST (35, 75 Sigma-Frankel units/L), ALT (76, 43 IU), lactate dehydrogenase (800, 800 
Wroblewski units), total protein (4.9, 6.4 g/dL) and albumin (2.75, 3.5 g/dL) for the northern 
brown bandicoot (Isoodon macrourus) and the eastern barred bandicoot (Perameles gunnii).
7 As 
expected, our data from P. bougainville were more similar to the results from the congener 
species P. gunnii than to those from the more distantly related species I. macrourus. 
Significant differences were observed for bandicoots from the 5 geographic locations for 
the majority of analytes. Genetics is unlikely to explain these differences since all extant P. 
bougainville belong to the same subspecies, P. bougainville bougainville
2. Nutrition, 
environment, social structures and unavoidable differences in the length of time of sample 
storage likely accounted for the observed variations.   
The tissue enzyme distributions were derived from only 3 animals in poor health and 
therefore the results may not represent the distribution of enzymes in healthy P. bougainville. 
Preferably, tissue from clinically normal individuals would have been used, but the endangered 
status of P. bougainville precluded this. Nonetheless, the results were consistent among the 3 
animals and also similar to findings in healthy dogs.
8  
Increased plasma AML activity is likely to specifically indicate recent or active 
pancreatic damage. The anatomical proximity of spleen and pancreas in bandicoots, and the 
occasional presence of pancreatic tissue within the gastrosplenic mesentery, as identified by 
examination of histologic sections of spleen samples (MDB, unpublished observation), supports 
the hypothesis that the apparent splenic AML activity likely resulted from the inadvertent 
inclusion of pancreatic tissue in 1 spleen sample. Based on other tissue enzyme results, elevated 
plasma CK activity is most likely to indicate recent or active damage to cardiac or skeletal 
muscle; AST is a non-specific indicator of cellular damage, so results must be interpreted 
together with the results of other tests and clinical signs.
9 P. bougainville had GGT activity in 
renal, intestinal and pancreatic tissue, but only negligible GGT activity was detected in liver. 
Based on the high GGT activity in kidneys, urinary GGT activity (relative to urinary creatinine 
concentration) may be an indicator of renal disease in this species.
9The ALP activity in liver 
suggests the potential for induction with hepatobiliary cholestasis.  
To our knowledge, this is the first study to determine clinical chemistry and tissue 
enzymology data from P. bougainville. These data will find application in the assessment of 
clinical chemistry samples from P. bougainville for the diagnosis of clinical and subclinical 
disease and population health monitoring.  
  
Acknowledgments 
 
This project was funded by the Australian Research Council in partnership with Murdoch 
University and the Western Australian Department of Environment and Conservation (DEC) 
under Linkage Project LP0455050. We acknowledge DEC Science Division for establishing the 
western barred bandicoot captive breeding program. Thanks to June Butcher and the volunteers 
at Kanyana Wildlife Rehabilitation Centre, Dr. Jeff Short and the Useless Loop Community 
Biosphere Project Group and Narrogin DEC staff for access to the western barred bandicoots in 
their care. Thanks also to the crew of ‘Spaniard’ and Australian Customs and the crew of the 
ACV Corio Bay for assistance with fieldwork on Bernier Island and Dorre Island. We gratefully 
acknowledge the staff of the Murdoch University clinical pathology laboratory for their technical 
advice and processing of the submitted samples. 
 
References 
1. IUCN List of Threatened Species. Available at: 
http://www.redlist.org/search/details.php?species=16569. Accessed July 21, 2007. 
2. Friend JA, Burbidge AA. Western barred bandicoot. In: Strahan R, ed. The Mammals of 
Australia. 2
nd ed. Frenchs Forest, NSW, Australia: Reed New Holland; 2002:178-180. 
3. Tyndale-Biscoe H. Bandicoots: fast living opportunists. In: Tyndale-Biscoe H. Life of 
Marsupials. Melbourne, VIC, Australia: CSIRO Publishing; 2005:165-181. 
4. O’Hara AJ, Warren KS, Swan RA, Sims C, Friend JA. Cutaneous papillomatosis and 
carcinomatosis in the endangered western barred bandicoot (Perameles bougainville) [abstract]. 
Vet Dermatol. 2004;15 Suppl 1(ix):25.  
5. Wagner RA, Wetzel, R. Tissue and plasma enzyme activities in juvenile green iguanas. Am J 
Vet Res. 1999;60:201-203. 
6. Lumsden JH, Mullen K. On establishing reference values. Can J Comp Med. 1978;42:293-
301. 
7. Parsons RS, Atwood J, Guiler, ER and Heddle, RWL. Comparative studies on the blood of 
monotremes and marsupials. I. Haematology. Comp Biochem Physiol. 1971;39B:203-208. 
8. Keller P. Enzyme activities in the dog: tissue analysis, plasma values and intracellular 
distribution. Am J Vet Res. 1981;42:575-581. 
9. Latimer KS, Mahaffey EA, Prasse KW, eds. Duncan and Prasse’s Veterinary Laboratory 
Medicine 4th ed. Ames, IA, USA: Iowa State Press; 2000.  
Figure Legend 
Figure 1. Enzyme activity in 9 tissue types from western barred bandicoots (Perameles 
bougainville) (n = 3). Each data point is the enzyme activity in U per gram of wet tissue weight. 
  
Table 1. Plasma clinical chemistry results for western barred bandicoots (Peramales bougainville) from 5 geographic locations in Australia.* 
Analyte  Dorre Island 
(n = 4) 
Bernier Island 
(n = 6) 
Heirisson Prong 
(n = 23) 
Dryandra Woodland 
(n = 15) 
Kanyana Wildlife Centre  
(n = 5)  P Value† 
ALP (U/L)  252–534  127–377  122–786   174–754  86–249  .078 
ALT (U/L)  46–66  60–115  35–81  45–78  78–202  .001 
AST (U/L)*  41–69  33–77  25–224  20–101  26–108  .112 
CK (U/L)  173–427  193–840  24–1814  117–368  68–103  .008 
Albumin (g/L)  30.3–33.0  31.8–40.0  30.3–38.4  24.4–39.1  34.0–40.8  .010 
Bilirubin (mmol/L)  0.7–4.8  1.1–5.6  0–2.5  2.0–6.6  1.1–4.0  <.001 
Calcium (mmol/L)  2.07–2.19  1.81–2.20  1.94–2.26  1.87–2.31  2.05–2.25  .276 
Cholesterol (mmol/L)  3.3–3.9  3.1–4.0  1.3–7.3  1.9–3.3  2.2–3.5  <.001 
Creatinine (mmol/L)  32–41  31–57  29–63  29–43  39–54  - 
Glucose (mmol/L)  6.7–8.2  7.0–13.3  5.0–9.5  6.7–10.6  8.0–12.4  .002 
Total protein (g/L)  52.3–60.6  53.7–62.1  44.1–57.6  38.6–64.2  52.0–55.9  .006 
Phosphate (mmol/L)  1.7–2.2  1.4–2.2  1.1–2.2  1.0–1.8  1.1–1.5  .012 
Urea (mmol/L)  11.0–12.0  10.6–17.6  7.8–12.7  6.9–17.8  11.2–13.5  - 
Globulins (g/L)  19.3–30.1  21.9–25.6  12.7–20.4  14.0–29.7  12.9–18.7  <.001 
Albumin/globulin ratio  1.01–1.71  1.41–1.81  1.82–2.72  1.15–2.34  1.84–3.09  - 
*Data are minimum–maximum. 
†Kruskall-Wallis test for geographic location using raw or transformed data with homogeneous variances (Levene’s test). 